Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Clare Stirzaker, Ph.D.
Clare Stirzaker, Ph.D., is group leader and senior lecturer at the Garvan Institute of Medical Research, University of South Wales in Sydney, Australia.
More GEN Content From This Contributor
- Market and Technology Analysis: lncRNAs and Epigenetic Modulations: Potential Hotspots